# EDGAR Filing Document

**Accession Number:** 0001538495
**File Stem:** 0001493152-26-012284
**Filing Date:** 2026-3
**Character Count:** 10385
**Document Hash:** cee07026da802dddcf2d1497dc08bbc6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-012284.hdr.sgml**: 20260324

**ACCESSION NUMBER**: 0001493152-26-012284

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260324

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260324

**DATE AS OF CHANGE**: 20260324

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Earth Science Tech, Inc.
- **CENTRAL INDEX KEY:** 0001538495
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 454267181
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55000
- **FILM NUMBER:** 26784331

**BUSINESS ADDRESS:**
- **STREET 1:** 8950 SW 74TH CT
- **STREET 2:** SUITE 101
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33156
- **BUSINESS PHONE:** (786) 375-7281

**MAIL ADDRESS:**
- **STREET 1:** 8950 SW 74TH CT
- **STREET 2:** SUITE 101
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33156

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ultimate Novelty Sports Inc.
- **DATE OF NAME CHANGE:** 20111230

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **March 24, 2026**

Commission File No. 000-55000

**<u>EARTH SCIENCE TECH, INC.</u>**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **florida** | **45-4267181** |
| (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | Identification No.) |

---

**<u>8950 SW 74th CT</u>**

**<u>Suite 1401</u>**

**<u>Miami, FL 33156, USA</u>**

(Address of principal executive offices, zip code)

**<u>(305) 724-5684</u>**

(Registrant's telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(g) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Stock $0.001 par value | ETST | Over the Counter Bulletin Board |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 7.01 Regulation FD Disclosure**

On March 24, 2026, the Company issued a press release (the "Release"), announcing the launch of MyOnlineConsultation.com, finalizing a fully vertically integrated telehealth and pharmacy ecosystem.

A copy of the Release issued by the Company on March 24, 2026, is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

**Item 9.01. Financial Statements and Exhibits.**

(d) *Exhibits* – The following exhibits are filed as part of this report:

---

| | |
|:---|:---|
| **Exhibit<br> No.** | **Description** |
| 99.1 | [Press release issued by the registrant on March 24, 2026](ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **EARTH SCIENCE TECH, INC.** | **EARTH SCIENCE TECH, INC.** |
| **Dated: March 24, 2026** | **By:** | ***/s/ Giorgio R. Saumat*** |
|  |  | Giorgio R. Saumat |
|  | **Its:** | **CEO and Chairman of the Board** |

---

## Exhibit 99.1

**Exhibit 99.1**

**Earth Science Tech, Inc. (ETST) Launches MyOnlineConsultation.com, Finalizing a Fully Vertically Integrated Telehealth and Pharmacy Ecosystem**

**MIAMI – March 24, 2026** – Earth Science Tech, Inc. (OTC: ETST) ("ETST" or the "Company"), a strategic holding company focused on a diversified healthcare portfolio, today announced the official launch of MyOnlineConsultation.com through MOCTeledoc, LLC, a fully integrated doctor network delivering both technology and clinical staffing solutions to digital health companies.

Following its beta phase, MOCTeledoc launches with an established cash-flow-positive status, validating the division's lean business model.

**<u>Financial and Strategic Highlights</u>**

● **Revenue Growth Strategy:** Management projects MOCTeledoc will become a significant revenue stream
 alongside the Company's compounding and direct-to-consumer divisions, which generated
 $25.9 million in revenue for the nine months ended December 31, 2025.

● **Vertical Integration:** The launch finalizes ETST's healthcare ecosystem by synchronizing
 MOCTeledoc's prescriber network directly with ETST's compounding pharmacies,
 RxCompound and Mister Meds as well as pharmacies outside the ecosystem.

● **Brand Consolidation:** This vertically integrated suite of services will be marketed nationwide
 under the Peaks brand to capture internal synergies and systematically drive cross-divisional
 revenue.

"Achieving cash-flow-positive results during our beta phase confirms the power of our product, and we anticipate this division will be immediately accretive to our bottom line as we roll it out nationwide," said Giorgio R. Saumat, ETST's CEO and Chairman of the Board. "By offering our custom platform and dedicated prescriber network as a turnkey service, we have not only created a new revenue stream but also established a powerful funnel for our in-house pharmacies."

**<u>Core MOCTeledoc Operational Capabilities</u>**

**●** **Turnkey Technology:** A scalable platform handling live video and asynchronous consultations, engineered
 to sync data seamlessly between providers and pharmacies.

● **Clinical Staffing:** Access to a credentialed network of licensed prescribers, removing the need
 for clients to recruit clinical staff.

● I **ntegrated Fulfillment:** Direct routing to the pharmacy to the facilities choice.

Platform inquiries can be directed to: <u>www.MyOnlineConsultation.com</u>

**About Earth Science Tech, Inc. (ETST)**

Earth Science Tech, Inc. is a diversified holding company focused on the health and wellness sector. Through its wholly-owned subsidiaries, ETST operates a vertically integrated portfolio that includes high-quality compounding pharmacies, telemedicine platforms, and targeted healthcare facilities. The Company currently owns RxCompoundStore.com and Mister Meds, two licensed compounding pharmacies providing sterile and non-sterile medications across a growing network of U.S. states. These operations are supported by Peaks Curative, DOConsultation.com, and Las Villas Health Care, providing patients with personalized care, telemedicine connectivity, and clinical support.

Beyond healthcare, ETST manages Avenvi, its real estate and asset management arm, and MagneChef, a direct-to-consumer brand leveraging proprietary IP for innovative kitchen products. The Company is also committed to social responsibility through the Earth Science Foundation, a non-profit dedicated to assisting patients with prescription costs.

To learn more, please visit: <u>www.EarthScienceTech.com</u>

**Forward-Looking Statements**

Except for historical information, the matters discussed herein may be considered "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as "expect," "expectation," "believe," "anticipate," "may," "could," "intend," "belief," "plan," "estimate," "target," "predict," "likely," "seek," "project," "model," "ongoing," "will," "should," "forecast," "outlook" or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company's actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company's products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.

**Contact:**

Hayden IR

James Carbonara

(646)-755-7412

<u>james@haydenir.com</u>

Brett Maas

(646) 536-7331

<u>brett@haydenir.com</u>